Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,002 | -34,627 | -107,641 | -76,847 | -48,996 |
| Depreciation Amortization | 972 | 562 | 1,344 | 923 | 624 |
| Other Working Capital | 20,451 | 13,662 | 1,096 | -2,216 | 555 |
| Other Operating Activity | 14,060 | 6,860 | 16,613 | 12,451 | 7,801 |
| Operating Cash Flow | $-41,519 | $-13,543 | $-88,588 | $-65,689 | $-40,016 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -216,955 | -43,297 | -56,047 | 45,733 | 52,618 |
| PPE Investments | -700 | -87 | -436 | -418 | -278 |
| Investing Cash Flow | $-217,655 | $-43,384 | $-56,483 | $45,315 | $52,340 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 120,772 | 1,780 | 252,679 | 88,823 | 73,360 |
| Financing Cash Flow | $120,772 | $1,780 | $252,679 | $88,823 | $73,360 |
| Beginning Cash Position | 201,195 | 201,195 | 93,587 | 93,587 | 93,587 |
| End Cash Position | 62,793 | 146,048 | 201,195 | 162,036 | 179,271 |
| Net Cash Flow | $-138,402 | $-55,147 | $107,608 | $68,449 | $85,684 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,519 | -13,543 | -88,588 | -65,689 | -40,016 |
| Capital Expenditure | -700 | -87 | -436 | -418 | -278 |
| Free Cash Flow | -42,219 | -13,630 | -89,024 | -66,107 | -40,294 |